| Name | Title | Contact Details |
|---|
Lincoln Lutheran is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lincoln Lutheran is based in Racine, WI. You can find more information on Lincoln Lutheran at www.llor.org
Children's Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Dayton, OH. To find more information about Children's Medical Center, please visit www.childrensdayton.org
Zuchelli is a Seaford, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zanthion protects the elderly from harm, automatically notifies near responders to avoid catastrophic damage, offers solace until help arrives, predicts future needs through artificial intelligence, and connects seniors to the world and their community. Zanthion is a pioneer in changing our social environment with future vision and use case (solution based) systems that improve the world based on open source, transparent, crowdsourced economic mechanisms that accurately assess what happened, inform the correct resources that the event has occurred, provide resources to the problem efficiently, and keep track of the efficiency of fixing the non-conformity. Our platform is generic and it is open. We embrace a responsible future.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.